Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05412797 · ClinicalTrials.gov registry record · NA

Use of a DeskCycle to Reduce Sedentary Behavior During the Workday

A NA study of Chronic Disease and Reduction, Weight, sponsored by Kent State University.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05412797: Completed NA study of Chronic Disease and Reduction, Weight, sponsored by Kent State University.

NCT05412797 is a NA study of Chronic Disease and Reduction, Weight that has completed, run by Kent State University. The registered enrollment target is 80 participants, below the 89,942-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05412797, a NA study of Chronic Disease and Reduction, Weight, has completed, sponsored by Kent State University.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research was to evaluate the effectiveness of a DeskCycle intervention in reducing sedentary behavior by increasing the time spent participating in light to moderate physical activity in a randomly selected group of desk job employees at Kent State University main campus. The study also assessed the feasibility of using the DeskCycle in the working environment, as well as the effect on weight and mood. The primary outcome of interest was the 'mean minutes of light to moderate physical activity'. Secondary outcomes include weight, mood score, and feasibility of using the DeskCycle. The study was a randomized controlled trial (RCT) with a cross-over design where differences between the intervention and control group were evaluated over an eight-week period, after which there was a switch and the DeskCycles were given to the control group to use for the eight-week period that followed. The allocation during the first eight-week period intervention will be done through random process.

Primary Outcome

Mean minutes of light to moderate physical activity

Interventions

  • BEHAVIORAL Cycling/Using a DeskCycle
  • BEHAVIORAL Regular activities

Study Locations (1)

Ohio

  • Kent State University - Kent

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2017-09-01
Est. Completion 2018-05-06
Phase NA
Kent State University

19 total trials

What the finished NCT05412797 record still lists

NCT05412797 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 89,942-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Chronic Disease appearing as the primary indexed condition, and to 2 interventions - of which Cycling/Using a DeskCycle is the first listed.

NCT05412797 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT05412797 about?

NCT05412797 is a clinical study titled "Use of a DeskCycle to Reduce Sedentary Behavior During the Workday". The purpose of this research was to evaluate the effectiveness of a DeskCycle intervention in reducing sedentary behavior by increasing the time spent participating in light to moderate physical activity in a randomly selected group of desk job employees at Kent State University main campus. The stu...

What is the current status of trial NCT05412797?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2017-09-01. Estimated completion is 2018-05-06.

What conditions does trial NCT05412797 study?

This clinical trial studies the following conditions: Chronic Disease, Reduction, Weight.

What interventions are being tested in trial NCT05412797?

The interventions under investigation include: Cycling/Using a DeskCycle (BEHAVIORAL), Regular activities (BEHAVIORAL).

Who is sponsoring clinical trial NCT05412797?

This trial is sponsored by Kent State University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05412797 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05412797's enrollment target sits among peer trials

80 35th of 48 higher than 13 of 48 other Chronic Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05412797, the US trial registry maintained by the National Library of Medicine. NCT05412797 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.